BTIG Research Reaffirms “Neutral” Rating for P3 Health Partners (NASDAQ:PIII)

P3 Health Partners (NASDAQ:PIII)‘s stock had its “neutral” rating reissued by equities researchers at BTIG Research in a research report issued to clients and investors on Friday,Benzinga reports.

PIII has been the topic of several other reports. Lake Street Capital decreased their target price on shares of P3 Health Partners from $20.00 to $12.50 and set a “buy” rating on the stock in a research report on Monday, November 17th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of P3 Health Partners in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $12.50.

P3 Health Partners Price Performance

Shares of NASDAQ:PIII opened at $5.11 on Friday. The company has a market cap of $36.84 million, a P/E ratio of -0.13 and a beta of 0.87. The business has a fifty day simple moving average of $7.32 and a 200-day simple moving average of $7.31. P3 Health Partners has a 52 week low of $4.97 and a 52 week high of $14.50. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 2.29.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($9.67) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($8.70) by ($0.97). The business had revenue of $345.25 million during the quarter, compared to analyst estimates of $346.64 million. P3 Health Partners had a negative return on equity of 302.33% and a negative net margin of 9.07%. Equities research analysts forecast that P3 Health Partners will post -0.67 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in P3 Health Partners stock. Cresset Asset Management LLC lifted its holdings in P3 Health Partners Inc. (NASDAQ:PIII) by 33.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 200,000 shares of the company’s stock after acquiring an additional 50,000 shares during the period. Cresset Asset Management LLC owned approximately 2.78% of P3 Health Partners worth $33,000 as of its most recent SEC filing. 7.75% of the stock is owned by hedge funds and other institutional investors.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.